U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156253) titled 'Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors' on Aug. 27.
Brief Summary: This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors
Study Start Date: Aug. 26
Study Type: INTERVENTIONAL
Condition:
Metastatic Solid Tumor
Ovarian Cancer
Breast Cancer
BRCA 1 /2 and / or HRD
Advanced Solid Tumors
Intervention:
DRUG: SYN818 and Olaparib will be administered
Patients will orally receive SYN818 and Olaparib
Recruitment Status: R...